Tuberculosis (TB) is an enormous global public health problem and has emerged as a public health emergency in the independent country of Georgia due to high rates of drug-resistant TB. Georgia has been designated as one of 27 high burden MDR-TB countries by the World Health Organization. In 2013, 11.2% of newly diagnosed TB cases and 38.1% of retreatment cases in Georgia had MDR-TB. Important progress has been made over the past decade in developing the capacity, where none existed initially, to carry out internationally recognized TB-related research in Georgia. A critical mass f MD and PhD-level investigators is now emerging in Georgia. These past efforts provide a foundation for us to build upon for our renewal application entitled, Emory-Georgia TB Research Training Program (EGTB-RTP). This application represents a collaboration between Emory University and the two key public health institutions in Georgia involved in TB treatment and control, the National Center for Tuberculosis and Lung Diseases (NCTLD) and the National Center for Disease Control and Public Health (NCDC). Key goals of this application include: to continue to enhance the capacity at the NCTLD and NCDC to carry out implementation science research and tackle challenges imposed by recent health care reform in Georgia; to build upon achievements made in the past grant cycle and leverage new opportunities for translational research given enhanced laboratory infrastructure at both the NCTLD and NCDC; to build capacity for research at the intersection of TB and non-communicable diseases (NCDs) which are emerging pubic health problems in Georgia; and expand laboratory, epidemiology and clinical/translational research on MDR- and XDR-TB. This application is focused on supporting expansion of in- country research and research training opportunities.
The specific aims of this renewal application include: 1) Continue to build human capacity to conduct high quality TB-related research in Georgia by Georgian investigators by providing long, medium and short-term research training and research opportunities to candidates with outstanding potential. This includes providing opportunities for research training in relevant laboratory, clinical, translational, epidemiologic, implementation science and behavioral/social science related research; 2) Enhance capacity for in-country research training by providing mentorship and leadership training for former Fogarty trainees who go on to serve as in-country mentors (paired with a U.S.-based mentor) for new trainees; 3) Focus research and research training activities on enhancing capacity to conduct research on drug resistant TB and strengthen the public health infrastructure for control of MDR- and XDR-TB; 4) Expand the focus of the EGTB-RTP to include research and research training at the intersection of TB and NCDs and risk factors for NCDs (TB-diabetes, TB-smoking, TB-mental health and TB-nutrition). Given the convergence of infectious diseases with NCDs there is an urgent need to have multidisciplinary collaborations and integrated strategies that incorporate both TB and NCDs.
Tuberculosis (TB) is an enormous global public health problem and has emerged as a public health emergency in the independent country of Georgia due to high rates of drug-resistant TB. The goal of this application entitled, 'Emory-Georgia TB Research Training Program (EGTB-RTP)', is to enhance TB-related research capacity in Georgia through research training of young Georgian investigators with great potential. Such efforts should result in building sustainable capacity to carry out internationally recognized TB-related research in Georgia and enhance the public health infrastructure for TB control in Georgia.
|Baliashvili, Davit; Magee, Matthew J; Kempker, Russell R et al. (2016) Contacts of retreatment tuberculosis cases with a prior poor treatment outcome are at increased risk of latent tuberculosis infection. Int J Infect Dis 43:49-50|
|Frediani, Jennifer K; Sanikidze, Ekaterina; Kipiani, Maia et al. (2016) Macronutrient intake and body composition changes during anti-tuberculosis therapy in adults. Clin Nutr 35:205-12|
|Abutidze, A; Bolokadze, N; Chkhartishvili, N et al. (2016) INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA. Georgian Med News :10-5|
|Salindri, Argita D; Kipiani, Maia; Kempker, Russell R et al. (2016) Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis. Open Forum Infect Dis 3:ofw126|
|Bablishvili, N; Tukvadze, N; Avaliani, Z et al. (2015) A comparison of the Xpert(Â®) MTB/RIF and GenoType(Â®) MTBDRplus assays in Georgia. Int J Tuberc Lung Dis 19:676-8|
|Van't Hoog, A H; Bergval, I; Tukvadze, N et al. (2015) The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study. BMC Infect Dis 15:473|
|Kempker, Russell R; Kipiani, Maia; Mirtskhulava, Veriko et al. (2015) Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis. Emerg Infect Dis 21:992-1001|
|Tukvadze, Nestan; Sanikidze, Ekaterina; Kipiani, Maia et al. (2015) High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial. Am J Clin Nutr 102:1059-69|
|Kempker, Russell R; Barth, Aline B; Vashakidze, Sergo et al. (2015) Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother 59:3149-55|
|Gegia, Medea; Magee, Matthew J; Kempker, Russell R et al. (2015) Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia. Bull World Health Organ 93:390-9|
Showing the most recent 10 out of 59 publications